Olympus today announced a new strategy that aims to increase cost savings but includes a workforce reduction of thousands.

EBR Systems enrolled the first patients in the WiSE-UP study evaluating its WiSE cardiac resynchronization therapy (CRT) ...

Investors have filed a class action complaint against Inspire Medical (NYSE:INSP) alleging violations of federal securities ...

Synchron announced today that it raised $200 million in a Series D financing round to support the commercialization of its ...

Sean Sciara announced on LinkedIn that he has taken on the position of chief commercial officer at Onward Medical.

Solventum (NYSE:SOLV) shares were unmoved after hours today on third-quarter results that came in ahead of the consensus ...

Smith+Nephew (NYSE: SNN) shares dipped before hours today on third-quarter results that failed to reach the consensus sales ...

Lungpacer Medical announced today that it enrolled the first six patients in its STARI clinical trial for its next-generation ...

After joining Medtronic as its first chief innovation officer in 2023, SVP Ken Washington says he's leaving on Nov. 14 ...

Wandercraft announced today that the FDA expanded the indications for its flagship Atalante X rehabilitation device.

Penumbra (NYSE:PEN) announced additional results from its STORM-PE trial of computer-assisted vacuum thrombectomy (CAVT).

Organon announced today that it agreed to sell its Jada intrauterine vacuum system to Laborie Medical Technologies for up to $465 million.